Displaying drugs 10451 - 10475 of 10844 in total
Etozoline
Etozoline is marketed in Europe under the names Diulozin, Elkapin, and Etopinil. Etozoline is a loop diuretic.
Experimental
Matched Description: … Etozoline is marketed in Europe under the names Diulozin, Elkapin, and Etopinil. …
Matched Salts cas: … 53-90-7 …
Matched Salts cas: … 53-90-7 …
B27PD
B27PD is under investigation in clinical trial NCT01195948 (Optiquel® as Corticosteroid-sparing Therapy for Chronic Noninfectious Uveitis).
Investigational
Matched Description: … B27PD is under investigation in clinical trial NCT01195948 (Optiquel® as Corticosteroid-sparing Therapy …
Tetrafluoroborate
Tetrafluoroborate is under investigation in clinical trial NCT02907073 (Positron Emission Tomography (PET) Imaging Studies With NIS Reporter).
Investigational
Matched Description: … Tetrafluoroborate is under investigation in clinical trial NCT02907073 (Positron Emission Tomography …
Estrane-3,17-dione
Estrane-3,17-dione is a potent inhibitor of isomerase.
Experimental
Matched Description: … Estrane-3,17-dione is a potent inhibitor of isomerase. …
MK-886
MK-886 is an experimental inhibitor of leukotriene synthesis.
Experimental
Matched Description: … MK-886 is an experimental inhibitor of leukotriene synthesis. …
Tabituximab barzuxetan yttrium Y-90
A version of tabituximab barzuxetan radiolabeled with yttrium-90.
Investigational
Matched Description: … A version of [tabituximab barzuxetan] radiolabeled with yttrium-90. …
Quisqualic acid
Quisqualic acid is an agonist at two subsets of excitatory amino acid receptors, ionotropic receptors that directly control membrane channels and metabotropic receptors that indirectly mediate calcium mobilization from intracellular stores. The compound is obtained from the seeds and fruit of Quisqualis chinensis.
Experimental
Matched Description: … The compound is obtained from the seeds and fruit of _Quisqualis chinensis_. ... Quisqualic acid is an agonist at two subsets of excitatory amino acid receptors, ionotropic receptors …
AL-034
AL-034 (TQ-A3334) is an oral toll-like receptor 7 agonist developed for the treatment of chronic hepatitis B (CHB) viral infection.
Investigational
Matched Description: … AL-034 (TQ-A3334) is an oral toll-like receptor 7 agonist developed for the treatment of chronic hepatitis …
SD118
SD118 was previously under investigation in Japan for a different indication and now, following re-profiling and evaluation in experimental animal models, has demonstrated its potential as a new oral therapy for neuropathic pain.
Investigational
Matched Description: … SD118 was previously under investigation in Japan for a different indication and now, following re-profiling ... and evaluation in experimental animal models, has demonstrated its potential as a new oral therapy for …
AZD-8186
AZD-8186 is under investigation in clinical trial NCT03218826 (PI3Kbeta Inhibitor AZD8186 and Docetaxel in Treating Patients Advanced Solid Tumors With PTEN or PIK3CB Mutations That Are Metastatic or Cannot Be Removed by Surgery).
Investigational
Matched Description: … AZD-8186 is under investigation in clinical trial NCT03218826 (PI3Kbeta Inhibitor AZD8186 and Docetaxel ... in Treating Patients Advanced Solid Tumors With PTEN or PIK3CB Mutations That Are Metastatic or Cannot …
1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidine
1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidine (PEPAP) is a synthetic analogue of meperidine. It is sold as a "synthetic heroin."
Experimental
Illicit
Matched Description: … 1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidine (PEPAP) is a synthetic analogue of meperidine. …
GX-G8
GX-G8 is a long-acting glucagon-like peptide 2 (GLP-2) being investigated for the treatment of short bowel syndrome.
Investigational
Matched Description: … GX-G8 is a long-acting glucagon-like peptide 2 (GLP-2) being investigated for the treatment of short …
S-3APG
S-3APG (S-3-[3-amino-phthalimido]-glutarimide) is a derivative of thalidomide with dual activity against B-cell neoplasias.
Investigational
Matched Description: … S-3APG (S-3-[3-amino-phthalimido]-glutarimide) is a derivative of thalidomide with dual activity against …
Sparsomycin
An antitumor antibiotic produced by Streptomyces sparsogenes. It inhibits protein synthesis in 70S and 80S ribosomal systems. [PubChem]
Experimental
Matched Description: … It inhibits protein synthesis in 70S and 80S ribosomal systems. [PubChem] …
Octacosanol
1-octacosanol is a straight-chain aliphatic 28-carbon primary fatty alcohol that is used as a nutritional supplement. This high–molecular-weight organic compound is the main component of a natural product wax extracted from plants . 1-octacosanol is reported to possess cholesterol-lowering effects, antiaggregatory properties, cytoprotective use, and ergogenic properties . It has...
Nutraceutical
Matched Description: … It has been studied as a potential therapeutic agent for the treatment of Parkinson's disease. ... This high–molecular-weight organic compound is the main component of a natural product wax extracted …
Willardiine
Willardiine is a compound isolated from seeds of Acacia willariana.
Experimental
Matched Description: … Willardiine is a compound isolated from seeds of _Acacia willariana_. …
Bapineuzumab
Bapineuzumab has been investigated for the treatment of Alzheimer's Disease.
Investigational
Matched Description: … Bapineuzumab has been investigated for the treatment of Alzheimer's Disease. …
Orteronel
Orteronel has been investigated for the treatment of Prostate Cancer.
Investigational
Matched Iupac: … 6-[(7S)-7-hydroxy-5H,6H,7H-pyrrolo[1,2-c]imidazol-7-yl]-N-methylnaphthalene-2-carboxamide …
Matched Description: … Orteronel has been investigated for the treatment of Prostate Cancer. …
Matched Description: … Orteronel has been investigated for the treatment of Prostate Cancer. …
Piclozotan
Piclozotan has been investigated for the treatment of Parkinson's Disease.
Investigational
Matched Description: … Piclozotan has been investigated for the treatment of Parkinson's Disease. …
Fanapanel
Fanapanel has been investigated for the treatment of Visual Acuity.
Investigational
Matched Iupac: … {[7-(morpholin-4-yl)-2,3-dioxo-6-(trifluoromethyl)-1,2,3,4-tetrahydroquinoxalin-1-yl]methyl}phosphonic …
Matched Description: … Fanapanel has been investigated for the treatment of Visual Acuity. …
Matched Description: … Fanapanel has been investigated for the treatment of Visual Acuity. …
Cannabinol
Cannabinol (CBN) is a physiologically inactive constituent of Cannabis sativa.
Experimental
Investigational
Matched Description: … Cannabinol (CBN) is a physiologically inactive constituent of Cannabis sativa. …
LY-2183240
LY-2183240 is an inhibitor of endocannabinoid reuptake/breakdown.
Investigational
Matched Description: … LY-2183240 is an inhibitor of endocannabinoid reuptake/breakdown.[A253037] …
BBP-671
BBP-671 is a small molecule activator of pantothenate kinases.
Investigational
Matched Description: … BBP-671 is a small molecule activator of pantothenate kinases. …
Bi104
Bi104 is being investigated for the treatment of Angelman syndrome.
Investigational
Matched Description: … Bi104 is being investigated for the treatment of Angelman syndrome. …
V24343
The anti-obesity drug, V24343, acts by targeting the CB1 receptor in the brain and suppressing a person's appetite.
Investigational
Matched Description: … The anti-obesity drug, V24343, acts by targeting the CB1 receptor in the brain and suppressing a person's …
Displaying drugs 10451 - 10475 of 10844 in total